Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Halting Tumor Progression via Novel Non-Hydroxamate Triazole-Based Mannich Bases MMP-2/9 Inhibitors; Design, Microwave-Assisted Synthesis, and Biological Evaluation
Fawzia Faleh Albelwi, Mohamed Teleb, Marwa M. Abu‐Serie, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10324-10324
Open Access | Times Cited: 23

Showing 23 citing articles:

Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013–2023)
Shriefa Almutairi, Hanin Moh’d Kalloush, Nour A. Manoon, et al.
Molecules (2023) Vol. 28, Iss. 14, pp. 5567-5567
Open Access | Times Cited: 39
Discovery of matrix metalloproteinase inhibitors as anti-skin photoaging agents
Feifan Li, Jia Zhi, Rui Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116152-116152
Closed Access | Times Cited: 7
Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation
Mohamed Reda Aouad, Meshal A. Almehmadi, Fawzia Faleh Albelwi, et al.
Bioorganic Chemistry (2022) Vol. 124, pp. 105816-105816
Closed Access | Times Cited: 25
Anticancer Activity of Mannich Bases: A Review of Recent Literature
Gheorghe Roman
ChemMedChem (2022) Vol. 17, Iss. 16
Closed Access | Times Cited: 22
Synthesis, molecular modeling investigation, molecular dynamic and ADME prediction of some novel Mannich bases derived from 1,2,4-triazole, and assessment of their anticancer activity
Sevda Manap, Hilal Medetalibeyoğlu, Ahsen Kılıç, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 21, pp. 11916-11930
Closed Access | Times Cited: 13
Novel Mannich bases derived from 1,2,4-triazoles: Design, synthesis, characterization, and glutathione S-transferase inhibition properties investigations
Onur Akyıldırım, Hilal Medetalibeyoğlu, Ercan Oğuz, et al.
Journal of Molecular Structure (2023) Vol. 1293, pp. 136321-136321
Closed Access | Times Cited: 12
Chemosensitization of non-small cell lung cancer to sorafenib via non-hydroxamate s-triazinedione-based MMP-9/10 inhibitors
Hosam H. Khalil, Mohamed M. El-Sheshtawy, Sherine N. Khattab, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107155-107155
Closed Access | Times Cited: 3
Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment
Jannik Paulus, Norbert Sewald
Journal of Peptide Science (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 2
A review of MMP-2 structures and binding mode analysis of its inhibitors to strategize structure-based drug design
S. K. Sanyal, Sk. Abdul Amin, Priyanka Banerjee, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 74, pp. 117044-117044
Closed Access | Times Cited: 13
The anti‐breast cancer therapeutic potential of 1,2,3‐triazole‐containing hybrids
Juntao Song, Shuai Zhang, Bo Zhang, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 3
Closed Access | Times Cited: 6
First-in-Class Star-Shaped Triazine Dendrimers Endowed with MMP-9 Inhibition and VEGF Suppression Capacity: Design, Synthesis, and Anticancer Evaluation
Nesreen S. Haiba, Hosam H. Khalil, Ahmed Bergas, et al.
ACS Omega (2022) Vol. 7, Iss. 24, pp. 21131-21144
Open Access | Times Cited: 10
Battling colorectal cancer via s-triazine-based MMP-10/13 inhibitors armed with electrophilic warheads for concomitant ferroptosis induction; the first-in-class dual-acting agents
Christine A. Morcos, Sherine N. Khattab, Nesreen S. Haiba, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106839-106839
Closed Access | Times Cited: 5
Non-small cell lung cancer sensitisation to platinum chemotherapy via new thiazole-triazole hybrids acting as dual T-type CCB/MMP-9 inhibitors
Hassan El Gamal, Khadiga Ahmed Ismail, A-Mohsen M. E. Omar, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 1
Thiophene-Linked 1,2,4-Triazoles: Synthesis, Structural Insights and Antimicrobial and Chemotherapeutic Profiles
Nada A. El-Emam, Mahmoud B. El‐Ashmawy, Ahmed A. B. Mohamed, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1123-1123
Open Access | Times Cited: 1
Design, Synthesis and Molecular Docking of Novel Acetophenone-1,2,3-Triazoles Containing Compounds as Potent Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors
Fawzia Faleh Albelwi, Hanaa M. Abdu Mansour, Maram M. Elshatanofy, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 799-799
Open Access | Times Cited: 8
Naringin dihydrochalcone potentially binds to catalytic domain of matrix metalloproteinase-2: molecular docking, MM-GBSA, and molecular dynamics simulation approach
Atul Kumar Singh, Shashank Kumar
Natural Product Research (2022) Vol. 37, Iss. 11, pp. 1851-1855
Open Access | Times Cited: 6
Enhancing the Anticancer Potential of Targeting Tumor-Associated Metalloenzymes via VEGFR Inhibition by New Triazolo[4,3-a]pyrimidinone Acyclo C-Nucleosides Multitarget Agents
Mohamed N. Abd Al Moaty, El Sayed H. El Ashry, Laila F. Awad, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2422-2422
Open Access | Times Cited: 5
Exploiting spirooxindoles for dual DNA targeting/CDK2 inhibition and simultaneous mitigation of oxidative stress towards selective NSCLC therapy; Synthesis, evaluation, and molecular modelling studies
Mohammad Shahidul Islam, Refaah Mousa Al‐Jassas, Abdullah Mohammed Al‐Majid, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 8, pp. 2937-2958
Closed Access
Microwave-assisted protocol towards synthesis of heterocyclic molecules: a comparative analysis with conventional synthetic methodologies (years 2019–2023): a review
Iffat Almas, Ayesha Malik, Nasır Rasool, et al.
Molecular Diversity (2024)
Closed Access
Structure optimization and molecular dynamics studies of new tumor-selective s -triazines targeting DNA and MMP-10/13 for halting colorectal and secondary liver cancers
Christine A. Morcos, Nesreen S. Haiba, Rafik W. Bassily, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access
Microwave-Assisted Synthesis of Fine Chemicals – Triazoles
Shainaz M. Landge, Charles Melvin, Asher Pence
Elsevier eBooks (2024)
Closed Access
Discovery of Novel Tris-1,2,3-Triazole-Based Hybrids as Vegfr2 Inhibitors with Potent Anti-Proliferative and Cytotoxicity Through Apoptosis Induction
Mosa Alsehli, Adeeb Al Sheikh Ali, Mohamed S. Nafie, et al.
(2024)
Closed Access
Syringin as TGF-βR1, HER2, EGFR, FGFR4 Kinase, and MMP-2 Inhibitor and Potential Cytotoxic Agent against ER+ Breast Cancer Cells
Ross D. Vasquez, Charlaine A. Aventurado, Agnes L. Castillo
Current Enzyme Inhibition (2022) Vol. 19, Iss. 1, pp. 55-64
Closed Access | Times Cited: 3
Page 1

Scroll to top